Health · 29 June 2026

Blood test could match patients to obesity drugs

Scientists are exploring how a simple blood test might help tailor weight-loss treatments for severe obesity patients. The test measures two hormones, GLP-1 and GIP, to predict how well drugs like semaglutide or tirzepatide might work. This preliminary study suggests personalising treatment could lead to better weight loss and health improvements.

By BriefTea Editorial · 29 June 2026 at 14:14

Reported by News-Medical · How we write briefs

Get the app

More briefs

HealthCorrecting hearing loss can cut dementia risk by almost half HealthMan changes life after doctor warns liver disease could kill him HealthSweetener used in chewing gum and jam linked to strokes and heart attacks HealthMouth cancer rates up a third in UK, often with no obvious cause HealthBox breathing helps calm stress and reduce anxiety, say experts HealthNHS managers warn spiralling costs could disrupt ADHD and autism care More health stories → Browse all stories →